Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Diabetic Medicine : a Journal of the British Diabetic Association|July 23, 2003
Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patientsS Hadjadj, Y Gallois, F Alhenc-Gelas, et al.
Diabete & Metabolisme|January 1, 1992
Predictive value of testing random urine sample to detect microalbuminuria in diabetic subjects during outpatient visitB Bouhanick, G Berrut, A M Chameau, et al.
Diabetes Care|October 1, 1994
Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patientsL Chaillous, M Delamaire, L Martignat, et al.
Diabetes Care|February 1, 1991
Telematic transmission of computerized blood glucose profiles for IDDM patientsA Billiard, V Rohmer, M A Roques, et al.
International Journal of Obesity (2005)|May 5, 2011
Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective studyA Lamri, C Abi Khalil, R Jaziri, et al.
Diabetes Research and Clinical Practice|April 11, 2017
The impact of level of education on vascular events and mortality in patients with type 2 diabetes mellitus: Results from the ADVANCE studyJ I Blomster, S Zoungas, M Woodward, et al.
Diabetes|April 1, 1996
Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutationG Velho, M M Byrne, K Clément, et al.
Diabetes & Metabolism|June 1, 1997
Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study GroupB Guerci, D Durain, H Leblanc, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 26, 2009
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)M Marre, J Shaw, M Brändle, et al.
Diabetes Research and Clinical Practice|June 15, 2010
The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trialS Zoungas, J Chalmers, A P Kengne, et al.
Pageof 26